云南省处方前置审核系统应用现状分析OA
Analysis of the application status of prescription pre-review systems in Yunnan province
目的 调研云南省医疗机构处方前置审核系统的应用现状,评估其系统功能及管理能力,为推动合理用药提供实践依据.方法 对云南省二级及以上公立医疗机构进行系统应用情况调研;构建包含处方即时审查、处方关联审查、审核规则设定、循证信息支持、处方权限管理及系统应用管理6个方面共39项指标的能力成熟度评价体系,对其中已应用系统的医疗机构进行能力评估.结果 共回收有效问卷100份,其中37家医疗机构已启用处方前置审核系统,主要集中于三级医院.系统多采用模块化架构,通过应用程序接口及中间件嵌入医院信息系统,具备一定的实时处方风险识别能力.处方前置审核能力成熟度评价结果显示,系统在适应证、禁忌证、配伍禁忌等基础审核功能上表现良好,但在肠外营养处方和特定疾病药物用量审查、患者个体化特征识别及审核规则设定等方面仍存在不足,审方中心建设与制度管理亦不完善.结论 云南省处方前置审核系统总体应用率不高,系统功能与管理机制尚需进一步完善.建议加强低等级医疗机构的信息化建设投入,探索区域化统一审核机制,推动审方工作规范化、智能化发展.
OBJECTIVE To investigate the application status of prescription pre-review systems in healthcare institutions of Yunnan province,evaluate their system functions and management capabilities,and provide a practical basis for promoting rational drug use.METHODS A questionnaire survey was conducted among public healthcare institutions at or above the secondary level in Yunnan province to investigate the deployment status of the systems.A capability maturity assessment framework was constructed,encompassing 6 dimensions and 39 indicators,including real-time prescription review,prescription correlation review,rule setting,evidence-based information support,prescription authority management,and system operation management.This framework was then used to evaluate the institutions that had implemented the pre-review systems.RESULTS A total of 100 valid questionnaires were collected,with 37 institutions having adopted prescription pre-review systems,mainly tertiary hospitals.The system predominantly adopted a modular architecture and was embedded into the hospital information system through application programming interfaces and middleware,providing certain capabilities for real-time prescription risk identification.Evaluation results indicated that basic functions such as reviewing indications,contraindications,and drug compatibility performed well,while deficiencies remained in functions related to parenteral nutrition prescription,review of drug dosage for specific diseases,individual patient characteristic recognition,and rule setting.Moreover,the construction of review centers and establishment of management systems were also not well-developed.CONCLUSIONS The overall application rate of prescription pre-review systems in Yunnan province remains low.System functions and management mechanisms require further improvement.It is recommended to enhance information infrastructure in lower-level institutions and explore regionally unified review models to promote standardized and intelligent development of prescription review practices.
徐帆;李特;尹文洁;李珂佳;李正富;陈洁;邬梅仙;陈瑞祥;李松梅;张国文
中国人民解放军联勤保障部队第920医院五华院区,昆明 650032||云南省药学会,昆明 650051云南省药学会,昆明 650051||云南省阜外心血管病医院/昆明医科大学附属心血管病医院药剂科,昆明 650102云南省药学会,昆明 650051||昆明医科大学附属延安医院药剂科,昆明 650051云南省药学会,昆明 650051||昆明医科大学第二附属医院药剂科,昆明 650101云南省药学会,昆明 650051||昭通市第一人民医院药剂科,云南 昭通 657000云南省药学会,昆明 650051||昆明市第三人民医院药剂科,昆明 650041云南省药学会,昆明 650051||昆明市官渡区人民医院药剂科,昆明 650211云南省药学会,昆明 650051||云南省第三人民医院药剂科,昆明 650011云南省药学会,昆明 650051||云南省中医医院药剂科,昆明 650021云南省药学会,昆明 650051||昆明医科大学第五附属医院/个旧市人民医院,云南 个旧 661000
医药卫生
前置审核处方审核医疗机构合理用药能力成熟度
pre-reviewprescription reviewhealthcare institutionsrational drug usecapability maturity
《中国药房》 2026 (1)
6-10,5
云南省科技厅科技计划项目(No.202101AY070001-293)云南省药学会科技计划项目(No.2024A01)
评论